Charles River Laboratories International (CRL) vs iSpecimen (ISPC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Charles River Laboratories International is the larger company by market cap ($14.46 billion vs $2.8 million), about 5221.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | CRL | ISPC |
|---|---|---|
| Share price | $300.30 | $1.10 |
| Market cap | $14.46B | $2.77M |
| 1-day change | -1.53% | +2.80% |
| YTD return | +50.54% | — |
| 1-year return | +76.54% | — |
| 5-year return | -25.58% | — |
| Forward P/E | 23.41 | — |
| EPS (TTM) | $-4.73 | $-53.97 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $4.02B | — |
| Revenue growth (YoY) | -0.85% | — |
| Net income (latest FY) | $-144.34M | — |
| Operating margin | 0.63% | — |
| Net margin | -3.59% | — |
| 52-week high | $333.30 | $40.04 |
| 52-week low | $146.20 | $1.02 |
| Distance from 52-week high | -9.90% | -97.25% |
| Analyst consensus | buy | — |
| Avg. price target upside | +1.57% | — |
| Average volume | 943.27K | 681.17K |
| Shares outstanding | 48.17M | 2.52M |
| Employees | 18,300 | — |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Biotechnology: Commercial Physical & Biological Resarch |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Charles River Laboratories International is about 5221.1 times larger than iSpecimen by market value ($14.46B vs $2.77M).
About Charles River Laboratories International
CRL stock →Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally.
Health Care · Biotechnology: Commercial Physical & Biological Resarch · 18,300 employees
CRL vs ISPC FAQ
Which is bigger, Charles River Laboratories International or iSpecimen?
Charles River Laboratories International (CRL) is larger, with a market capitalization of $14.46B compared with $2.77M for iSpecimen (ISPC).
Are Charles River Laboratories International and iSpecimen in the same industry?
Yes. Both are classified in the Biotechnology: Commercial Physical & Biological Resarch industry within the Health Care sector.